Trial reportBMC anesthesiology2025
The effect of intraoperative dexmedetomidine versus ketamine on postoperative pain in patients receiving a femoral nerve block for total knee arthroplasty: a randomized trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain control after total knee arthroplasty (TKA) remains challenging. Intraoperative dexmedetomidine and ketamine are commonly used in multimodal analgesia to reduce pain and opioid requirements. This study aimed to compare their effects on opioid consumption, pain, hemodynamics and satisfaction. MATERIALS AND
methodsThis prospective, randomized, double-blind study included 104 adults (≥ 18 years) with ASA I-III status undergoing TKA under spinal anesthesia. After all patients had received spinal anesthesia, they were randomized into two equal groups (n = 52). Group D received dexmedetomidine (1 µg/kg loading dose, then 0.5 µg/kg/h); Group K received ketamine (0.1 mg/kg/h without a loading dose). Sedation level was titrated to achieve a modified Observer's Assessment of Alertness/Sedation (OAA/S) score of 3-4. Postoperatively, a single-shot femoral nerve block was administered to all patients. Primary outcome was total opioid consumption in 24 h. Secondary outcomes included Visual Analog Scale (VAS) scores, hemodynamic parameters, side effects and patient satisfaction.
resultsTramadol use in 24 h was similar (Group D: 175.29 ± 44.62 mg; Group K: 155 ± 44.48 mg; p = 0.44). VAS scores were comparable at all time points. Time to ambulation was longer in the ketamine group (Group D: 4.4 ± 1.4 h; Group K: 5.3 ± 2.5 h; p = 0.04). Group D showed significantly lower heart rate and blood pressure values at multiple time points (p < 0.001). Patient satisfaction was high in both groups and no hypotension or bradycardia occurred in any group.
conclusionAlthough no significant differences were found between dexmedetomidine and ketamine, both agents provided comparable analgesia and opioid consumption, supporting their potential role as adjuvants in multimodal analgesia for patients undergoing TKA.
trial registrationISRCTN11906298, retrospectively registered on 13.06.2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.